Nucleic acid aptamers for neurodegenerative diseases

Biochimie. 2018 Feb:145:73-83. doi: 10.1016/j.biochi.2017.10.026. Epub 2017 Nov 20.

Abstract

The increased incidence of neurodegenerative diseases represents a huge challenge for societies. These diseases are characterized by neuronal death and include several different pathologies, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease and transmissible spongiform encephalopathies. Most of these pathologies are often associated with the aggregation of misfolded proteins, such as amyloid-ß, tau, α-synuclein, huntingtin and prion proteins. However, the precise mechanisms that lead to neuronal dysfunction and death in these diseases remain poorly understood. Nucleic acid aptamers represent a new class of ligands that could be useful to better understand these diseases and develop better diagnosis and therapy. In this review, several of these aptamers are presented as well as their applications for neurodegenerative diseases.

Keywords: Alzheimer; Aptamers; Neurodegenerative disease; Parkinson; Prion; Tauopathies.

Publication types

  • Review

MeSH terms

  • Amyloidogenic Proteins* / antagonists & inhibitors
  • Amyloidogenic Proteins* / metabolism
  • Animals
  • Aptamers, Nucleotide* / chemistry
  • Aptamers, Nucleotide* / therapeutic use
  • Humans
  • Neurodegenerative Diseases* / diagnosis
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism
  • Neurodegenerative Diseases* / pathology
  • Proteostasis Deficiencies* / diagnosis
  • Proteostasis Deficiencies* / drug therapy
  • Proteostasis Deficiencies* / metabolism
  • Proteostasis Deficiencies* / pathology

Substances

  • Amyloidogenic Proteins
  • Aptamers, Nucleotide